Dr Reddys Laboratories RDY
NYSE RDY
$14.86 -0.05 (-0.34%)
As of: Nov 9, 2026 · 10:00 AM EST

Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Cash & Current Investments of $138.41 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 23.9% from $111.67 million a year earlier and up 17.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Cash & Current Investments came in at $193.79 million, down 29.7% from FY2025.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -1.9% (FY2021 to FY2026).
  • In prior fiscal years, Dr Reddys Laboratories' Cash & Current Investments was $275.75 million in FY2025 (+177.0%), $99.53 million in FY2024 (+30.1%), $76.49 million in FY2023 (-66.6%) and $229.15 million in FY2022 (+7.4%).
  • Quarterly Cash & Current Investments has run from a low of $58.87 million in fiscal Q1 2025 to a high of $295.25 million in fiscal Q3 2022 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in six of the last eight quarters, with growth averaging 43.3%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was fiscal Q3 2022, with growth of 399.7%; the weakest was fiscal Q3 2023, with a decline of 74.4%.
  • According to Business Quant data, Cash & Current Investments for the three prior fiscal quarters was $118.2 million (Q1 2027), $193.79 million (Q4 2026) and $207.83 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,242.36 Bn 1,215.98 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 668.81 Bn 588.67 Bn 17.30 Bn 17.23 Bn
3 AbbVie 515.10 Bn 483.11 Bn 13.12 Bn 10.77 Bn
4 Merck 362.39 Bn 325.33 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 314.14 Bn 287.38 Bn - 505.00 Mn
6 Astrazeneca 291.23 Bn 265.12 Bn 13.26 Bn 7.94 Bn
7 Amgen 248.23 Bn 199.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 208.43 Bn 183.54 Bn 6.73 Bn 6.44 Bn
9 Pfizer 165.78 Bn 113.13 Bn 12.56 Bn 14.27 Bn
10 Dr Reddys Laboratories 12.39 Bn 11.73 Bn 472.93 Mn 138.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 138.41 Mn
Jun 30, 2026 118.20 Mn
Mar 31, 2026 193.79 Mn
Dec 31, 2025 207.83 Mn
Sep 30, 2025 111.67 Mn
Jun 30, 2025 105.37 Mn
Mar 31, 2025 275.07 Mn
Dec 31, 2024 151.91 Mn
Sep 30, 2024 135.34 Mn
Jun 30, 2024 58.87 Mn
Mar 31, 2024 99.76 Mn
Dec 31, 2023 91.55 Mn
Sep 30, 2023 169.20 Mn
Jun 30, 2023 88.07 Mn
Mar 31, 2023 76.88 Mn
Dec 31, 2022 75.56 Mn
Sep 30, 2022 111.63 Mn
Jun 30, 2022 79.81 Mn
Mar 31, 2022 229.02 Mn
Dec 31, 2021 295.25 Mn
API Access

Dr Reddys Laboratories Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RDY&period=max&api_key=YOUR_API_KEY